微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 2.25% | -63.77% | -40.48% | 91/159 | 1.21% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | 3.78% | -18.53% | 101.06% | 49/159 | 0.26% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | 1.88% | -3.09% | -58.68% | 58/159 | -0.37% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 4.55% | 25.69% | -26.73% | 62/159 | -9.52% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 6.21% | 24.7% | 33.84% | 60/159 | 4.23% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 4.64% | 19.28% | 139.18% | 41/159 | 2.66% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 1.94% | -13.39% | -46.41% | 59/159 | 2.32% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 3.62% | -4.49% | -27.31% | 74/159 | -1.03% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 4.98% | 191.23% | 28.02% | 71/159 | 2.34% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 3.89% | 109.14% | 73.66% | 54/159 | 1.46% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 2.24% | 198.67% | -40.9% | 54/159 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 3.79% | 205.65% | 121.64% | 84/159 | 0.67% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 1.71% | -3.39% | -8.06% | 97/159 | 2.8% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 1.86% | 41.98% | 148% | 89/159 | 2.16% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 0.75% | -11.76% | -39.52% | 99/159 | 1.57% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 1.24% | -29.14% | -29.94% | 105/159 | 0.75% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 1.77% | -44.51% | 35.11% | 108/159 | 4.43% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 1.31% | -46.31% | 54.12% | 106/159 | 2.94% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 0.85% | -36.09% | -51.43% | 97/159 | 2.49% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 1.75% | -63.69% | -45.14% | 100/159 | 3.58% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 3.19% | -24.94% | 30.74% | 80/159 | 3.03% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 2.44% | -20.26% | 83.46% | 82/159 | 4.19% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 1.33% | 1.53% | -72.41% | 60/159 | 2.19% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 4.82% | -9.06% | 13.41% | 86/159 | 2.53% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 4.25% | 8.97% | 38.89% | 76/159 | 7.48% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 3.06% | 10.87% | 133.59% | 67/159 | 4.96% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 1.31% | 33.67% | -75.28% | 73/159 | 2.41% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 5.3% | 53.62% | 35.9% | 83/159 | 6.99% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 3.9% | 30.43% | 41.3% | 79/159 | 7.18% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 2.76% | 135.9% | 181.63% | 71/159 | 4.6% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 0.98% | 27.27% | -71.59% | 77/159 | 2.54% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 3.45% | 44.96% | 15.38% | 96/159 | 9.61% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 2.99% | -10.48% | 155.56% | 77/159 | 8.29% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 1.17% | -25.48% | 51.95% | 91/159 | 5.58% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 0.77% | 18.46% | -67.65% | 68/159 | 2.09% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 2.38% | -24.92% | -28.74% | 94/159 | 6.19% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 3.34% | 12.08% | 112.74% | 67/159 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 1.57% | -20.3% | 141.54% | 73/159 | 3.48% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 0.65% | 8.33% | -79.5% | 64/159 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | 3.17% | 15.69% | 6.38% | 79/159 | 11.27% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 2.98% | 17.79% | 51.27% | 55/159 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | 1.97% | 233.9% | 228.33% | 56/159 | 4.87% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | 0.6% | -30.23% | -78.1% | 57/159 | 2.41% | 华东医药 | 26.63% | 行业排名> |